Cedar Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-7
Closed -$551 286
2024
Q2
$551 Hold
7
﹤0.01% 301
2024
Q1
$610 Hold
7
﹤0.01% 341
2023
Q4
$577 Hold
7
﹤0.01% 278
2023
Q3
$549 Sell
7
-11
-61% -$921 ﹤0.01% 288
2023
Q2
$1.59K Hold
18
﹤0.01% 281
2023
Q1
$1.45K Sell
18
-2
-10% -$163 ﹤0.01% 281
2022
Q4
$1.55K Hold
20
﹤0.01% 276
2022
Q3
$2K Sell
20
-8
-29% -$719 ﹤0.01% 304
2022
Q2
$3K Hold
28
﹤0.01% 307
2022
Q1
$3K Hold
28
﹤0.01% 339
2021
Q4
$3K Buy
+28
New +$3.24K ﹤0.01% 335
2017
Q4
Sell
-18
Closed -$1K 142
2017
Q3
$1K Hold
18
﹤0.01% 130
2017
Q2
$2K Hold
18
﹤0.01% 127
2017
Q1
$1K Hold
18
﹤0.01% 132
2016
Q4
$1K Hold
18
﹤0.01% 125
2016
Q3
$2K Hold
18
﹤0.01% 114
2016
Q2
$2K Buy
+18
New +$1.46K ﹤0.01% 119

Other funds holding MDT

Cedar Wealth Management's MDT Position: Q3 2024 in Review

Cedar Wealth Management sold out of Medtronic (MDT) in Q3 2024, closing a stake of 7 shares — an estimated $551 sold.

Cedar Wealth Management first reported a position in MDT in Q2 2016 and held it in 17 quarters. The position peaked at $3K in Q2 2022. 2,069 funds tracked by Wall St. Rank hold MDT as of Q3 2024.

  • Cedar Wealth Management reported no remaining Medtronic position as of Q3 2024 after selling out during the quarter.
  • Cedar Wealth Management sold 7 Medtronic shares in Q3 2024, an estimated $551.
  • Cedar Wealth Management first reported a position in Medtronic in Q2 2016 and held it in 17 quarters.
  • Cedar Wealth Management's Medtronic position peaked at $3K in Q2 2022.
  • 2,069 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.

Based on Cedar Wealth Management's 13F filing for Q3 2024, filed 8 Nov 2024.